Item 16. Form 10-K Summary

Form 10-K Summary

None.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange

Act of 1934, the Registrant has duly

caused this report to be signed on its behalf by the undersigned,

thereunto duly authorized.

Henry Schein, Inc.

By: /s/ STANLEY M. BERGMAN

Stanley M. Bergman

Chairman and Chief Executive Officer

February 28, 2024

Pursuant to the requirements of the Securities Exchange Act of 1934, this

report has been signed below by the

following persons on behalf of the Registrant and in the capacities and on

the dates indicated.

Signature

Capacity

Date

/s/ STANLEY M. BERGMAN

Chairman, Chief Executive Officer

February 28, 2024

Stanley M. Bergman

and Director (principal executive officer)

/s/ RONALD N. SOUTH

Senior Vice President, Chief

Financial Officer

February 28, 2024

Ronald N. South

(principal financial and accounting officer)

/s/ JAMES P.

BRESLAWSKI

Vice Chairman, President

and Director

February 28, 2024

James P.

Breslawski

/s/ MARK E. MLOTEK

Executive Vice President,

Chief Strategic Officer and

Director

February 28, 2024

Mark E. Mlotek

/s/ MOHAMAD ALI

Director

February 28, 2024

Mohamad Ali

/s/ DEBORAH DERBY

Director

February 28, 2024

Deborah Derby

/s/ CAROLE T. FAIG

Director

February 28, 2024

Carole T. Faig

/s/ JOSEPH L. HERRING

Director

February 28, 2024

Joseph L. Herring

/s/ KURT P.

KUEHN

Director

February 28, 2024

Kurt P.

Kuehn

/s/ PHILIP A. LASKAWY

Director

February 28, 2024

Philip A. Laskawy

/s/ ANNE H. MARGULIES

Director

February 28, 2024

Anne H. Margulies

/s/ STEVEN PALADINO

Director

February 28, 2024

Steven Paladino

/s/ CAROL RAPHAEL

Director

February 28, 2024

Carol Raphael

/s/ SCOTT SEROTA

Director

February 28, 2024

Scott Serota

/s/ BRADLEY T. SHEARES,

PH.D.

Director

February 28, 2024

Bradley T. Sheares,

Ph.D.

/s/ REED V.

TUCKSON, M.D., FACP

Director

February 28, 2024

Reed V.

Tuckson, M.D., FACP